Dhoot jumps 37% and Molbio gains 21% on debut after strong IPOs; see issue prices, funds raised and business details.
According to MarketsandMarkets™, the Cancer Diagnostics Market is projected to reach USD 44.92 billion by 2031 from USD 29.86 billion in ...
Molbio Diagnostics Listing: Molbio Diagnostics Limited shares made a debut at Rs 980 per share on NSE, reflecting a gain of ...
Shares of Molbio Diagnostics were currently trading at Rs 946.25 at 10:07 IST on the BSE, representing a premium of 17.26% as compared with the issue price of Rs 807.
Molbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO ...
Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular ...
Insight Molecular Diagnostics discussed the potential use of donor-derived cell-free DNA testing in heart transplant surveillance during a virtual session featuring transplant cardiologist Dr. Max ...
The Temasek- and Motilal Oswal Group-backed company's ₹940-crore IPO was subscribed 70.26 times by the close of bidding on ...
11h
Body Fluid Analysis Market by Product, Technology, Fluid Type, Application - Global Forecast to 2031
The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031 at a 6.9% CAGR. Growth is driven by rising neurological, musculoskeletal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results